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Abstract Ecthyma gangrenosum (EG) involves
necrotic cutaneous lesions caused by bacteria, mainly
Pseudomonas aeruginosa, and is usually seen in
immunocompromised patients with septicemia. How-
ever, clinically similar infections have been published
with fungi as etiologic agents. We present a case of an
EG-like lesion due to Fusarium oxysporum confirmed
by clinical diagnosis, culture and molecular identifi-
cation and discuss the definition of EG.
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Introduction
Ecthyma gangrenosum (EG) is generally defined as an
infection with multiple necrotic cutaneous ulcers caused
by species of Pseudomonas, mainly P. aeruginosa, or
Aeromonas. The disorder is usually seen in immuno-
compromised patients, particularly thosewith underlying
malignant disease. Occurrence in immunocompetent
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individuals is highly exceptional [1]. Since 1980s, data
have accumulated on awider bacterial spectrumof gram-
negative agents like Escherichia coli, Citrobacter fre-
undii, Klebsiella pneumonia, Morganella morganii and
various Pseudomonas species [2, 3]. Also some fungi
havebeen reported tocause clinically similar lesions, e.g.,
species of Candida, Aspergillus, and Curvularia [4].
Thus, the disease definition for some authors is deter-
mined by the etiologic agent and for others by clinical
features. Nevertheless, the name is infrequently applied
to fungal infections. This confusion may mask a wider
prevalence of EG-like infections, which otherwise may
have been reported under a wide spectrum of fungal
diseases.Wepresent a fungal case of anEG-like infection
in an immunocompetent patient caused by Fusarium
oxysporum and discuss the definition of EG.
Case Presentation
A 17-year-old male from southwestern China with
epilepsy presented with a painless ulcer on his right leg
which was clinically suspected as being dry gangrene.
The lesion started 2 months earlier when he was
injured during an epileptic insult by a wooden bench.
Initial lesions were in the form of small, painless
papules which quickly progressed to a painless ulcer
with a black eschar over a period of 2 weeks. All
laboratory investigations were within normal ranges,
and in particular, no immune deficiency was apparent.
However, the patient had a history of epilepsy for
which he was on carbamazepine for 7 years. Exam-
ination of the skin lesion showed a 5 9 13 cm skin
ulcer with black eschar, i.e., the ulcer edge appeared to
‘‘roll over’’ and took the shape of a tough, erythema-
tous and fibrous ring. The black eschar adhered tightly
without discharge of pus or granules (a1, a2). Upon
first visit, the case was diagnosed as EG (Fig. 1).
Identification of the Fungal Etiological Agent
A skin biopsy was taken from the lesion and direct
examination (KOH 10 %) showed multiple thin
hyaline hyphae (b1, b2). Histopathological examina-
tion showed irregular, hyaline hyphae in the H&E-
stained tissue (c1, c2). Culture on Sabouraud’s glucose
agar (SGA) showed white colonies with a light brown
pigment excreted into the medium. Phenotypic iden-
tification of this isolate resulted in a Fusarium species.
Since fungal hyphae were visible in histopathological
slides, the medical judgment of the case was changed
from EG to an EG-like fungal infection. Subsequently,
voriconazole (400 mg/day orally) was added to the
therapeutic plan at day 14 after admission. Two weeks
after the start of antifungal treatment, the patient
received surgical debridement and continued on oral
voriconazole for another 2 weeks with noticeable
improvement. The patient did not return for follow-up
visits. The isolate was preserved and deposited in the
CBS-KNAW reference collection with accession
number CBS 140424.
Subculturing of the isolate for a more thorough
morphological study was performed on Malt Extract
Agar (MEA) and Oatmeal Agar (OA) with incuba-
tion times of 1 week at 25, 33 and 37 C. Rapidly
growing, hairy, pink–violet colonies were observed
after incubation on MEA after 5 days at 28 C.
Microscopic morphology showed short, single, lat-
eral monophialides (flask-shaped projections) in the
aerial mycelium. Macroconidia were fusiform,
slightly curved, 1–3 septate, 21.4–38.5 lm in length
and 3.2–4.5 lm in width. Microconidia were abun-
dant, not arranged in chains, 0–1 septate,
6.4–14.3 lm in length and 2.8–4.3 lm in width
(d1–d4). Optimal growth was observed at 27 C;
maximum growth temperature was 37 C. On the
basis of culture and microscopy, the fungus was
provisionally identified as F. oxysporum.
Genomic DNA was extracted from a culture grown
on MEA following a cetyltrimethyl ammonium bro-
mide protocol as described previously [5]. The rDNA
internal transcribed spacer region (ITS) was analyzed
as routine marker using primers ITS1 and ITS4. Since
ITS is not a recommended locus for reliable identifi-
cation of Fusarium species, the partial translation
elongation factor 1-alpha (TEF1) and the partial RNA
polymerase second largest subunit (rPB2) were also
analyzed. PCR amplification and sequencing of the
partial fragments were, respectively, done for TEF1
with primers EF1 andEF2R and for RPB2with primers
RPB2-7cR and RPB2-5F2 [5]. To perform identifica-
tion, a similarity search with the sequences of each
gene was done using the BLAST tool of the NCBI
database, the FUSARIUM-ID database and the Fusar-
ium MLST database. These BLAST searches yielded
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100 % similarity scores with several submissions
under the name F. oxysporum. The ITS, TEF1 and
rPB2 nucleotide sequenceswere deposited inGenBank
with accession numbers KT794176, KT794174 and
KT794173, respectively.
Antifungal Susceptibility Testing
Antifungal susceptibility testing was performed
according to CLSI M38A (Clinical and Laboratory
Standards Institute 2008) method, slightly modified by
Fig. 1 a1 Initial infection; a2 After 2 weeks of treatment; b1,
b2 KOH mount of the swab collected from the lesion showing
fungal hyaline hyphae (magnification, 940); c1, c2 fungal
hyphae seen with H&E stain from the biopsy; d1 growth of
white colonies and purple pigmentation on MEA at 25 C.; d2–
d4 septate macroconidia and microconidia. All scale bars
10 lm
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Al-Hatmi et al. [6] and demonstrated that the fungus
had a low minimum inhibitory concentrations (MICs)
of 1 lg/ml against amphotericin B and high MICs
above published epidemiological cut off values
(ECVs) [7], for itraconazole ([16 lg/ml), voricona-
zole (8 lg/ml), posaconazole ([16 lg/ml), isavu-
conazole (8 lg/ml), anidulafungin ([16 lg/ml),
micafungin ([16 lg/ml), and fluconazole ([64 lg/
ml).
Discussion
At present EG is generally defined as a condition
pathognomonic for Pseudomonas aeruginosa or
related bacteria in immunocompromised patients. In
the current literature, a much wider definition is often
maintained, including variable etiology and variable
host factors, also including immunocompetent. In our
view, the gangrenous clinical appearance is the unique
feature of the infection and should determine the
definition, as follows: (1) Pathogens, which may be
bacteria but also fungi, yeasts or mycobacteria are
isolated from blood cultures and skin biopsies [8], (2)
The host is immunocompromised. (3) Clinically, the
lesions demonstrate hemorrhagic pustules that lead to
necrotic ulcers which evolve into gangrenes with
black scab and in a later stage become surrounded by a
red halo. (4) Histopathology shows a necrotic epider-
mis and papillary dermal edema; venules are con-
gested and red blood cell extravasation is noted in the
papillary dermis; secondary thrombosis of the arteri-
oles, tissue edema and separation of the epidermis
leads to the specific picture of EG.
Consequently, our case was interpreted as EG-like,
with presence of fungal hyphae, but a difference was
noted in the fact that our patient was an immunocom-
petent individual. Although fungal agents are mostly
reported from immunocompromised patients with EG,
an immunocompromised status was judged not nec-
essary [8]. This makes the clinical appearance of local
gangrene even less specific. While originally Pseu-
domonas bacteria were part of the definition, now also
other agents including fungi such as the general
opportunist genus Fusarium can be involved, and the
immune status of the host also appears variable. For all
these reasons, it seems to us that a definition of EG by
medical aspects of clinical features, and histopathol-
ogy is most appropriate.
Reported fungal opportunists of EG-like and EG
infections are Aspergillus fumigatus, Candida albi-
cans, C. tropicalis, Curvularia sp., Exserohilum sp.,
Fusarium solani, Metarhizium anisopliae, Mucor
pusillus, Scedosporium boydii and Neoscytalidium
dimidiatum [4]. To this list, F. oxysporum can be
added. Histopathology showed that local invasion
with fungal elements was present in epidermis and
dermis. An extensive literature search revealed six
cases since 1975 in neutropenic patients due to F.
solani or other Fusarium species that were listed as EG
[9–14]. Our patient, without known immune defi-
ciency, had a history of trauma during which the
fungus could have been implanted in the skin. The
eschar was tightly attached to the ulcer, suggesting
that fungal EG might be different from bacterial EG,
which would favor reference to fungal infections as
‘‘EG-like.’’ Though, more cases have to be studied to
confirm this clinical difference. In most EG and EG-
like cases, the clinical picture is specific; differential
diagnosis should consider warfarin-induced skin
necrosis, cocaine-induced skin necrosis, calciphy-
laxis, septic emboli, loxoscelism, diabetic microan-
giopathy, disseminated intravascular coagulation,
paraneoplastic extensive necrotizing vasculitis, pyo-
derma gangrenosum, livedoid vasculopathy, antineu-
trophil cytoplasmic antibody -associated vasculitis,
cutaneous necrotizing vasculitis due to familial
Mediterranean fever, and necrosis secondary to the
use of vasoactive drugs [15, 16].
Treatment of our patient was only for 2 weeks with
voriconazole, but the beginning of a curative effect
was seen during this short period. The loftiness around
the lesion became flatter and the surface of the eschar
became dry. EG is an ominous sign in immunocom-
promised patients, especially with P. aeruginosa.
However, dermatologists should be aware that other
pathogens such as fungi can cause clinically indistin-
guishable lesions. In most cases, the cutaneous
appearance constitutes an important physical clue to
the clinical diagnosis as an EG or EG-like lesion, that
is black scab and surrounded by a red halo. Given the
fact that the etiologic agent can be of bacterial and of
fungal nature, it is essential that the pathogen is
identified.
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